This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jiali Mao: Innovator in Cardiac Dysfunction Treatment
Introduction
Jiali Mao is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac dysfunction. His innovative approach has led to the development of a unique application that leverages TREM2 macrophages for therapeutic purposes.
Latest Patents
Jiali Mao holds a patent titled "Application of TREM2 macrophages in the preparation of drugs for the treatment of cardiac dysfunction." This invention discloses the application of TREM2 macrophages in drug preparation aimed at treating cardiac dysfunction. It reveals for the first time the existence of a macrophage subset that expresses a triggering receptor on myeloid cells-2 in cardiac-derived macrophages. These macrophages play a crucial role in recognizing and reducing mitochondrial damage, thereby maintaining cardiac metabolic balance. The TREM2 macrophages hold significant application value in the treatment of cardiac dysfunction, showcasing Jiali Mao's innovative contributions to medical science. He has 1 patent to his name.
Career Highlights
Jiali Mao is affiliated with Zhejiang University, where he continues to advance his research and innovations. His work is characterized by a strong focus on the intersection of immunology and cardiology, aiming to improve treatment outcomes for patients suffering from cardiac issues.
Collaborations
Some of his notable coworkers include Kai Zhang and Shiyu Chen, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Jiali Mao's innovative work in the application of TREM2 macrophages represents a significant advancement in the treatment of cardiac dysfunction. His contributions to medical science are paving the way for new therapeutic strategies that could benefit many patients.